Am Heart J
- CARULLI E, McGarvey M, Chabok M, Panoulas V, et al
Corrigendum to ;;Transcoronary cooling and dilution for cardioprotection during
revascularisation for ST-segment elevation myocardial infarction: design and
rationale of the STEMI-Cool study''. [Am Heart J. 2025:282:40-50].
Am Heart J. 2025;288:89.
- MESSINGER MC, Ashburn NP, Chait JS, Snavely AC, et al
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast
United States.
Am Heart J. 2025 May 13:S0002-8703(25)00157-7. doi: 10.1016/j.ahj.2025.
- JAMES S, Christoffersen AD, David JP, Hacker M, et al
Effect of Once-Weekly Subcutaneous Semaglutide on Arterial Inflammation in People
with Type 2 Diabetes and Cardiovascular Disease Using PET-MRI: Primary Results of
a Randomized, Double-Blind, Placebo-Controlled Trial.
Am Heart J. 2025 May 7:S0002-8703(25)00156-5. doi: 10.1016/j.ahj.2025.
Am J Cardiol
- AKBAR UA, Taha MB, Arshad HB, Patel KV, et al
Young Adults Undergoing Percutaneous Coronary Intervention for Myocardial
Infarction in the United States, 2011-2023.
Am J Cardiol. 2025 May 10:S0002-9149(25)00295.
- LALANI C, Sharma RK, Sevilla-Cazes J, Kennedy K, et al
Outcomes of Percutaneous Coronary Interventions Following Transcatheter Aortic
Valve Replacement: Insights from the CathPCI Registry.
Am J Cardiol. 2025 May 10:S0002-9149(25)00294.
- MARK DG, Huang J, Lee KK, Sax DR, et al
Implementation of a High-Sensitivity Cardiac Troponin Assay and Diagnostic
Protocol for Suspected Acute Coronary Syndrome.
Am J Cardiol. 2025 May 8:S0002-9149(25)00292.
Am J Emerg Med
- CAMP S, Elhamdani A, Zinabu S, McGinnis P, et al
Serum troponin testing and adverse cardiovascular outcomes in supraventricular
tachycardia: A retrospective study from TriNetX.
Am J Emerg Med. 2025;95:7-15.
Angiology
- CAP M, Karaduman M, Zhou T, Erdogan E, et al
An Automated User-friendly Software for Fast Computation of Blood Flow Velocity
From Coronary Angiographic Images.
Angiology. 2025 May 15:33197251338474. doi: 10.1177/00033197251338474.
Ann Thorac Surg
- LAMY A
The Downfall of RITA as a Second Conduit in Coronary Artery Bypass Surgery.
Ann Thorac Surg. 2025 May 8:S0003-4975(25)00402.
Can J Cardiol
- WU Y, Liu J, Du X, Li M, et al
Prognostic Value of Angiography-derived Index of Microcirculatory Resistance in
Patients with diabetes and ST-Segment Elevation Myocardial Infarction.
Can J Cardiol. 2025 May 9:S0828-282X(25)00334-4. doi: 10.1016/j.cjca.2025.
Circ Cardiovasc Interv
- ISHIKAWA T, Natsuaki M, Watanabe H, Morimoto T, et al
Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without
Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial.
Circ Cardiovasc Interv. 2025 May 14:e015197.
- DEMIR OM, Sinha A, Rahman H, Ryan M, et al
Pressure-Derived Indices in the Left Main Coronary Artery: Insights From
Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels.
Circ Cardiovasc Interv. 2025 May 12:e015320.
Circ Cardiovasc Qual Outcomes
- SAYED A, Michos ED, Navar AM, Virani SS, et al
Global Sociodemographic Disparities in Ischemic Heart Disease Mortality According
to Sex, 1980 to 2021.
Circ Cardiovasc Qual Outcomes. 2025 May 13:e011648.
Circulation
- SATTAR N, Weerakkody GJ, McGuire DK, Kosiborod MN, et al
The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels
in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular
Disease: Post hoc Analyses of SURPASS 4.
Circulation. 2025;151:1430-1432.
- WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
Correction to: Sedentary Behavior and Light-intensity Physical Activity During
Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart
Association.
Circulation. 2025;151:e1000.
- BOHULA EA, Landzberg MJ, Menon V, Alviar CL, et al
Palliative and End-of-Life Care During Critical Cardiovascular Illness: A
Scientific Statement From the American Heart Association.
Circulation. 2025 May 15. doi: 10.1161/CIR.0000000000001334.
- REITAN C, Andell P, Hofmann R, Jernberg T, et al
Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss
of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort
Study".
Circulation. 2025;151:e988-e989.
- ZHANG Z, Yang X, Zhang Z
Letter by Zhang et al Regarding Article, "Excess Mortality and Loss of Life
Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
Circulation. 2025;151:e986-e987.
Clin Cardiol
- OZKAN U, Budak M, Gurdogan M, Ozturk G, et al
KCNQ1 Polymorphism in the Context of Ischemic Cardiomyopathy: A Potential Key to
Decision-Making for Device Implantation.
Clin Cardiol. 2025;48:e70148.
Eur Heart J
- COYLE M, McEvoy JW
Age-specific troponin thresholds: considerations for the fifth universal
definition of myocardial infarction.
Eur Heart J. 2025 May 9:ehaf308. doi: 10.1093.
Int J Cardiol
- ZARRAR M
Growth Differentiation Factor 15 and Empagliflozin in acute myocardial
infarction: Correspondence.
Int J Cardiol. 2025 May 11:133365. doi: 10.1016/j.ijcard.2025.133365.
J Am Coll Cardiol
- SCHWARTZ GG, Cobbaert CM
Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and
Cardiovascular Implications.
J Am Coll Cardiol. 2025;85:1855-1857.
J Cardiovasc Pharmacol
- BAHARDOUST M, Yarahmadi D, Aghakhani Z, Mahdi Kakoienejad M, et al
Comparison of short-term treatment with atorvastatin versus rosuvastatin for
preventing contrast-associated acute kidney injury in patients undergoing
coronary angiography/percutaneous coronary intervention: a systematic review and
meta-analysis.
J Cardiovasc Pharmacol. 2025 May 14. doi: 10.1097/FJC.0000000000001718.
- BURNETT H, Cichewicz A, Natani H, Bhowmik D, et al
Comparative Efficacy of Non-Statin Lipid-Lowering Therapies in Patients With
Hypercholesterolemia at Increased Cardiovascular Risk: An Updated Network
Meta-Analysis.
J Cardiovasc Pharmacol. 2025 May 13. doi: 10.1097/FJC.0000000000001712.
J Thromb Haemost
- VAN EDOM CJ, Fiorelli F, Balthazar T, Monteagudo-Vela M, et al
Discrepancy between parallel anti-Xa and activated partial thromboplastin time is
related to mortality in patients with Impella-supported cardiogenic shock.
J Thromb Haemost. 2025;23:1810-1816.
- MOUSSA MD, Abou-Arab O, Staessens S, Jungling M, et al
Comparison of the effects of phosphorylcholin versus heparin-based surface
coating on clinical and histologic outcomes during veno-arterial extracorporeal
membrane oxygenation support: a propensity score weighted analysis.
J Thromb Haemost. 2025;23:1879-1892.
JAMA
- GARRISON SR, Bakal JA, Kolber MR, Korownyk CS, et al
Antihypertensive Medication Timing and Cardiovascular Events and Death: The
BedMed Randomized Clinical Trial.
JAMA. 2025 May 12:e254390. doi: 10.1001/jama.2025.4390.
Lancet
- LEE SJ, Kim BK
Obicetrapib-ezetimibe combination therapy for patients with atherosclerotic
cardiovascular disease.
Lancet. 2025 May 5:S0140-6736(25)00827-X. doi: 10.1016/S0140-6736(25)00827.
Mol Cell Biochem
- CAO X, Wang T, Mu G, Chen Y, et al
Dysregulated homocysteine metabolism and cardiovascular disease and clinical
treatments.
Mol Cell Biochem. 2025 May 10. doi: 10.1007/s11010-025-05284.
Prog Cardiovasc Dis
- ROULEAU CR, Garland SN
A social ecological perspective on interventions to address short sleep duration
in adults with coronary heart disease.
Prog Cardiovasc Dis. 2025 May 13:S0033-0620(25)00074.
- TOTH PP, Banach M
No second chances: Cardiovascular death is the most frequent incident event among
patients with coronary artery calcium.
Prog Cardiovasc Dis. 2025 May 13:S0033-0620(25)00073.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016